Onconetix, Inc.
ONCO
$1.01
$0.055.31%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -61.81% | -67.70% | -34.58% | -9.34% | 153.70% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -61.81% | -67.70% | -34.58% | -9.34% | 153.70% |
| Cost of Revenue | -85.22% | -87.58% | -93.14% | -80.65% | -40.29% |
| Gross Profit | -35.80% | -40.02% | 242.77% | 205.28% | 197.20% |
| SG&A Expenses | -19.20% | -37.29% | -45.64% | -49.15% | -45.23% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -27.09% | -44.30% | -53.05% | -53.02% | -46.71% |
| Operating Income | 19.12% | 38.59% | 55.25% | 56.66% | 54.89% |
| Income Before Tax | 82.99% | 76.51% | 3.26% | 15.13% | -24.50% |
| Income Tax Expenses | 100.05% | 100.05% | -556.65% | -1,068.35% | -588.23% |
| Earnings from Continuing Operations | 82.71% | 76.09% | 4.77% | 16.83% | -22.85% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 82.71% | 76.09% | 4.77% | 16.83% | -22.85% |
| EBIT | 19.12% | 38.59% | 55.25% | 56.66% | 54.89% |
| EBITDA | 13.87% | 34.06% | 54.18% | 57.46% | 57.17% |
| EPS Basic | -- | -- | -- | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | -- | -- | -- | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | -- | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | -- | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |